Interferon Reshapes Clonal Competition in Myeloproliferative Neoplasms

Company Weill Cornell Medicine (with Mount Sinai, New York Genome Center, Memorial Sloan Kettering, New York Blood Center) Event Type Peer-Reviewed Publication Modality Genotype-Resolved Single-Cell Multiomics of Interferon Alfa Therapy Target CALR- and JAK2-Mutated Hematopoietic Stem/Progenitor Cells Disease Area Essential Thrombocythemia and Polycythemia Vera Summary…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *